Skip to main content

Avivagen Inc(VIV-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.005
Day High0.005
Open:0.005
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Avivagen: Bottom 25 Performing Stocks Year-to-Date on TSX-V (VIV)
The Globe and Mail
Avivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)
The Globe and Mail
Avivagen: Bottom 25 Performing Stocks Year-to-Date on TSX-V (VIV)
The Globe and Mail
Avivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)
The Globe and Mail
Avivagen: Top 10 Undervalued Drug Manufacturers Industry Stocks (VIV)
The Globe and Mail
Avivagen: Bottom 25 Performing Stocks Year-to-Date on TSX-V (VIV)
Baystreet
Stocks in play: Avivagen Inc
Baystreet
Stocks in play: Avivagen Inc.
AccessWire
AVIVAGEN to Present at The LD 500 Virtual Conference

Profile

Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.